These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29419707)

  • 1. Assessing Variation in Implantable Cardioverter Defibrillator Therapy Guideline Adherence With Physician and Hospital Patient-sharing Networks.
    Moen EL; Bynum JP; Austin AM; Skinner JS; Chakraborti G; O'Malley AJ
    Med Care; 2018 Apr; 56(4):350-357. PubMed ID: 29419707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey.
    Castellanos JM; Smith LM; Varosy PD; Dehlendorf C; Marcus GM
    Heart Rhythm; 2012 Jun; 9(6):874-81. PubMed ID: 22306794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Marzec LN; Peterson PN; Bao H; Curtis JP; Masoudi FA; Varosy PD; Bradley SM
    JAMA Cardiol; 2017 May; 2(5):561-565. PubMed ID: 28122073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician network position and patient outcomes following implantable cardioverter defibrillator therapy.
    Moen EL; Bynum JP; Skinner JS; O'Malley AJ
    Health Serv Res; 2019 Aug; 54(4):880-889. PubMed ID: 30937894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of patients with new cardiovascular implantable electronic devices: is adherence to the experts' recommendations associated with improved outcomes?
    Hess PL; Mi X; Curtis LH; Wilkoff BL; Hegland DD; Al-Khatib SM
    Heart Rhythm; 2013 Aug; 10(8):1127-33. PubMed ID: 23773989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators.
    Sherazi S; Zareba W; Daubert JP; McNitt S; Shah AH; Aktas MK; Block RC
    Cardiol J; 2010; 17(3):267-73. PubMed ID: 20535717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-evidence-based ICD implantations in the United States.
    Al-Khatib SM; Hellkamp A; Curtis J; Mark D; Peterson E; Sanders GD; Heidenreich PA; Hernandez AF; Curtis LH; Hammill S
    JAMA; 2011 Jan; 305(1):43-9. PubMed ID: 21205965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do physicians' attitudes toward implantable cardioverter defibrillator therapy vary by patient age, gender, or race?
    Al-Khatib SM; Sanders GD; O'Brien SM; Matlock D; Zimmer LO; Masoudi FA; Peterson E
    Ann Noninvasive Electrocardiol; 2011 Jan; 16(1):77-84. PubMed ID: 21251138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low referral pattern for implantable defibrillator therapy in a tertiary hospital: referral physician survey and Monte Carlo simulation.
    Mohamad T; Jacob S; Kommuri NV; Modi S; Aravindhakshan R; Lieberman R
    Am J Ther; 2011 Sep; 18(5):350-4. PubMed ID: 20335787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey.
    Haugaa KH; Tilz R; Boveda S; Dobreanu D; Sciaraffia E; Mansourati J; Papiashvili G; Dagres N
    Europace; 2017 Apr; 19(4):660-664. PubMed ID: 28431077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing physician knowledge regarding indications for a primary prevention implantable defibrillator and potential barriers for referral.
    Bernier R; Raj SR; Tran D; Reyes L; Sauve M; Sumner GL; Exner DV; Sandhu RK
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1334-1341. PubMed ID: 28841249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
    JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF.
    Mehra MR; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; O'Connor CM; Reynolds D; Walsh MN; Fonarow GC
    Heart Rhythm; 2009 Dec; 6(12):1727-34. PubMed ID: 19959119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Population-Based Study of Adherence to Guideline Recommendations and Appropriate-Use Criteria for Implantable Cardioverter Defibrillators.
    Bernier R; Al-Shehri M; Raj SR; Reyes L; Lockwood E; Gulamhusein S; Williams R; Valtuille L; Sivakumaran S; Hruczkowski T; Kimber S; Exner DV; Sandhu RK
    Can J Cardiol; 2018 Dec; 34(12):1677-1681. PubMed ID: 30527158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.
    Roth GA; Poole JE; Zaha R; Zhou W; Skinner J; Morden NE
    J Am Coll Cardiol; 2016 Mar; 67(9):1062-1069. PubMed ID: 26940927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers.
    Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Petersen HH; Torp-Pedersen C; Riahi S; Jøns C
    Europace; 2018 Feb; 20(2):301-307. PubMed ID: 28339659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.
    Kaiser DW; Tsai V; Heidenreich PA; Goldstein MK; Wang Y; Curtis J; Turakhia MP;
    Heart Rhythm; 2015 Oct; 12(10):2086-93. PubMed ID: 25982720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consideration of patient age and life expectancy in implantable cardioverter-defibrillator referral.
    Dewland TA; Hsu JC; Castellanos JM; Smith LM; Marcus GM
    Am Heart J; 2013 Jul; 166(1):164-70. PubMed ID: 23816036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.